The PennZone

  • Home
  • Health
  • Business
  • Non-profit
  • Technology
  • Music
  • Construction
  • Sports
  • Entertainment

Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
The PennZone/10291181

Trending...
  • Dr. Curtis Rasmussen Shares Leadership and AI Insights on Lead Empowered TV
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • The New Monaco of the South (of Italy)
ECT and Antidepressants: Hidden Dangers
A new study reveals widespread misinformation about electroshock therapy among patients. CCHR says parents are similarly misled about ECT use on teens and children as young as five. Moreover, antidepressants—often a precursor to ECT recommendations—also carry significant risks.

LOS ANGELES - PennZone -- A new study reveals that patients feel misinformed about the risks of electroconvulsive therapy (ECT), reinforcing the argument that the practice should be banned, according to mental health industry watchdog, Citizens Commission on Human Rights International. Study participants shared accounts of immediate cognitive and memory impairments, as well as long-term effects such as profound loss of abilities, memory, humanity, and personal connections, along with psychological harm and a sense of brain damage. Published in Qualitative Health Research, the study highlights that many patients are denied recognition of their adverse outcomes, which intensifies their struggles.[1]

CCHR says that in the U.S., young teens and children under six have undergone ECT. Lacking the ability to consent, parents—often misinformed about its safety and efficacy—agree to the practice. They are likely unaware that no clinical trials have substantiated safety and efficacy.

The information leaflets provided to patients regarding ECT have been found to minimize the prevalence or severity of memory loss, researchers found. The study says, "Following ECT, there is a possibility of permanent adverse effects including memory and cognitive impairment" and that "Iatrogenic harm, the infliction of harm through medical interventions, is a known possible outcome of ECT."

While the survey of consumers occurred in the United Kingdom, CCHR says that similar patient complaints about ECT have been reported to the group in the U.S. and other countries. Recently, CCHR International supported groups helping a Minnesota man who was threatened with court-ordered ECT when he refused to consent to it. The man had already received 17 courses of involuntary shock and was terrified of undergoing more.

More on The PennZone
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
  • Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
  • Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
  • CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health

In its letter to the psychiatric hospital attempting to force ECT upon the 44-year-old man, CCHR cited numerous United Nations reports that say involuntary, forced electroshock constitutes torture and that U.S. courts have acknowledged ECT's risks to patients, including brain damage, memory loss, and cognitive disability.[2]

ECT is often recommended when other treatments have not worked, especially antidepressants. These drugs also have iatrogenic side effects. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing safety alerts for 30 antidepressants, after Thomas Kingston, husband of Lady Gabriella Kingston, daughter of Prince and Princess Michael of Kent, fatally shot himself due to adverse effects from these drugs.[3] A coroner ruled Mr. Kingston shot himself due to the adverse effect of the medications he had been prescribed, which included the common antidepressant citalopram. According to evidence given at his inquest, Mr. Kingston had complained that another antidepressant was making him anxious. A medical expert at the inquest, Dr David Healy, suggested this was a sign that SSRI antidepressants "did not suit him" and that he should not have been prescribed citalopram following this. "We need a much more explicit statement saying that these drugs can cause people to commit suicide who wouldn't have otherwise," he said.[4]

MHRA data shows 71 alerts since 2014 over deaths linked to citalopram and 114 for sertraline.[5]

According to JAMA Psychiatry, ECT is recommended after two antidepressants have failed as "first-line" treatments. CCHR says consumers are often misinformed and, therefore, are unaware that treatment side effects can drive them to have suicidal feelings. When these increase, they are further misled into believing it is their mental state "at fault," rather than the adverse mental and physical effects synonymous with both antidepressants and electroshock.

More on The PennZone
  • Goatimus Launches Dynamic Context: AI Prompt Engineering Gets Smarter
  • Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM

During the holiday season, CCHR is committed to raising awareness about individuals experiencing sorrow because of a lost one, loneliness, being away from family, and more. People can become unwitting candidates for having such emotions misdiagnosed as "holiday depression," and put at risk of being prescribed antidepressants. CCHR wants to see different, non-invasive approaches taken to help individuals and strongly urges against agreeing to electroshock therapy, recommending legal support if necessary to prevent it from being forced on any individual.

Founded 55 years ago by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has achieved significant milestones in mental health reform. In 1976, it played a pivotal role in securing the first-ever prohibition on electroshocking minors in California. Similarly, in 2014, CCHR helped enact legislation in Western Australia that made administering ECT to minors a criminal offense. The organization was also instrumental in prompting the Food and Drug Administration to hold hearings on the potential suicidal effects of SSRI antidepressants, leading to the FDA issuing warnings of suicidal ideation for individuals under 24.
Sources:

[1] Emily Shipwright, David Murphy, "Long-Term Adverse Effects After Electroconvulsive Therapy (ECT): A Narrative Analysis Exploring People's Experiences, Meaning-Making, and Coping," Qualitative Health Research, 2024, journals.sagepub.com/doi/10.1177/10497323241303391

[2] "CCHR Supports Minnesota Man's Opposition to Enforced Electroshock Treatment," CCHR International, 4 Dec. 2024, www.cchrint.org/2024/12/04/cchr-supports-opposition-to-enforced-electroshock-treatment/

[3] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[4] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[5] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • OctoNerv Completes Functional Prototype of Electronic Breast Nipple Implant (EBNI)
  • Zivra AI Launches Real-Time Business Health and Financial Intelligence for SMEs
  • Obey God Clothing Launches Urban Christian Apparel Line Serving All Ages
  • PA Golf Cart World Launches NEV Pre-Inspection & Compliance Service for 2026
  • Dr. Curtis Rasmussen Shares Leadership and AI Insights on Lead Empowered TV
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
  • Are You Hiring The Right Heater Repair Company in Philly?
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Indian Peaks Veterinary Hospital Launches Updated Dental Services Page for Boulder Pet Owners
  • Dugan Air Donates $10,000 to Indian Creek Schools
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 224
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 206
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
  • Children Rising Appoints Marshelle A. Wilburn as New Executive Director
  • Bent Danholm Joins The American Dream TV as Central Florida Host
  • NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • God's Meal Barrel Combats the Increased Community Need in 2025

Similar on PennZone

  • At Your Service Plumbing Named a 2025 Nextdoor Neighborhood Fave
  • Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
  • Insight Holistic Imaging Introduces In-LightN Advanced Thermography - New Personalized Wellness Scr
  • TrueNorth Wellness Services Welcomes a New CEO
  • Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
  • Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
  • CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
  • Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
  • American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
  • Lineus Medical Completes UK Registration for SafeBreak® Vascular
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us